VIA
ASXC

Vident Investment Advisory’s Asensus Surgical, Inc. ASXC Stock Holding History

Vident Investment Advisory’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-32,358
Closed -$1.79K – 394
2016
Q1 		$1.79K Buy
32,358
+1,524
+5% +$65.3K 0.11% 329
2015
Q4 		$994K Buy
30,834
+3,065
+11% +$98.7K 0.13% 303
2015
Q3 		$816K Buy
+27,769
New +$1.03M 0.11% 258

Other funds holding ASXC

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vident Investment Advisory's ASXC Position: Q2 2016 in Review

Vident Investment Advisory sold out of Asensus Surgical, Inc. (ASXC) in Q2 2016, closing a stake of 32,358 shares — an estimated $1.79K sold.

Vident Investment Advisory first reported a position in ASXC in Q3 2015 and held it in 3 quarters. The position peaked at $994K in Q4 2015. 84 funds tracked by Wall St. Rank hold ASXC as of Q2 2016.

  • Vident Investment Advisory reported no remaining Asensus Surgical, Inc. position as of Q2 2016 after selling out during the quarter.
  • Vident Investment Advisory sold 32,358 Asensus Surgical, Inc. shares in Q2 2016, an estimated $1.79K.
  • Vident Investment Advisory first reported a position in Asensus Surgical, Inc. in Q3 2015 and held it in 3 quarters.
  • Vident Investment Advisory's Asensus Surgical, Inc. position peaked at $994K in Q4 2015.
  • 84 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2016.

Based on Vident Investment Advisory's 13F filing for Q2 2016, filed 12 Aug 2016.